GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,371.50p
   
  • Change Today:
      24.00p
  • 52 Week High: 1,671.00p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,081.56m
  • Volume: 9,104,549
  • Market Cap: £55,978m
  • RiskGrade: 129
  • Beta: 0.01

Latest ShareCast News

London close: FTSE finishes week just shy of 9,000

By Josh White

Date: Friday 18 Jul 2025

(Sharecast News) - London stocks ended higher on Friday, supported by a positive shift in investor sentiment following US consumer confidence data.

GSK Regulatory News

US FDA review extended for Blenrep 23-Jul-2025 17:00 RNS
Transaction in Own Shares 23-Jul-2025 07:00 RNS
Transaction in Own Shares 22-Jul-2025 07:00 RNS
Transaction in Own Shares 21-Jul-2025 07:00 RNS
Director/PDMR Shareholding 18-Jul-2025 15:30 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,371.50p
Change Today 24.00p
% Change 1.78 %
52 Week High 1,671.00p
52 Week Low 1,264.00p
Volume 9,104,549
Shares Issued 4,081.56m
Market Cap £55,978m
Beta 0.01
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.83% below the market average19.83% below the market average19.83% below the market average19.83% below the market average19.83% below the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Price Trend
29.46% below the market average29.46% below the market average29.46% below the market average29.46% below the market average29.46% below the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Income
81.72% above the market average81.72% above the market average81.72% above the market average81.72% above the market average81.72% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
30.97% below the market average30.97% below the market average30.97% below the market average30.97% below the market average30.97% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 15
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 23-Jul-2025

Time Volume / Share Price
15:29 0 @ 1,369.00p
15:07 0 @ 1,371.00p
15:06 0 @ 1,370.00p
15:01 1 @ 1,369.50p
15:01 3 @ 1,369.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page